MEDICOX Co., Ltd. (KOSDAQ:054180)
South Korea · Delayed Price · Currency is KRW 2,295.00
-270.00 (-10.53%)
At close: Jul 2, 2025
MEDICOX Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 35.59 | 376.6 | 1,228 | 1,810 | 2,979 | 4,191 |
Short-Term Investments | 100 | 100 | 3,015 | 300 | 1,800 | 300 |
Trading Asset Securities | 3,017 | 3,017 | 1,785 | 15,579 | 19,989 | 14,251 |
Cash & Short-Term Investments | 3,152 | 3,493 | 6,028 | 17,689 | 24,768 | 18,742 |
Cash Growth | -65.28% | -42.05% | -65.92% | -28.58% | 32.15% | 496.81% |
Accounts Receivable | 1,658 | 1,889 | 2,139 | 2,195 | 2,509 | 1,428 |
Other Receivables | 1,965 | 150.96 | 20.77 | 1,256 | 1,329 | 77.51 |
Receivables | 4,073 | 2,450 | 3,030 | 3,815 | 4,208 | 2,506 |
Inventory | 1,188 | 1,178 | 1,054 | 1,772 | 1,438 | 918.56 |
Prepaid Expenses | - | 52.46 | 234.17 | 210.97 | 455.06 | 177.96 |
Other Current Assets | 465.62 | 319.28 | 2,910 | 6,549 | 11,020 | 3,929 |
Total Current Assets | 8,879 | 7,494 | 13,256 | 30,037 | 41,889 | 26,273 |
Property, Plant & Equipment | 43,886 | 44,279 | 52,063 | 51,476 | 48,516 | 46,960 |
Long-Term Investments | 9,503 | 9,503 | 16,011 | 16,020 | 12,794 | 27,974 |
Goodwill | - | - | - | - | 2,109 | - |
Other Intangible Assets | 6.03 | 7.94 | 16.25 | 24.22 | 20.24 | 8.21 |
Long-Term Accounts Receivable | -0 | -0 | 0 | - | - | - |
Other Long-Term Assets | 6,982 | 6,972 | 73.55 | 191.9 | 3,882 | 1,254 |
Total Assets | 69,256 | 68,255 | 81,419 | 97,760 | 110,434 | 102,479 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 583.74 | 702.83 | 500.07 | 861.49 | 594.56 | 717.01 |
Accrued Expenses | 162.86 | 210.49 | 278.57 | 199.92 | 200.49 | 238.08 |
Short-Term Debt | 8,499 | 8,462 | 15,095 | 15,252 | 16,270 | 18,471 |
Current Portion of Long-Term Debt | - | - | 2,486 | - | - | - |
Current Portion of Leases | 1,230 | 1,237 | 653.62 | 838.36 | 1,261 | 827.31 |
Current Unearned Revenue | - | - | - | 7.68 | 7.68 | - |
Other Current Liabilities | 8,269 | 5,367 | 4,788 | 13,480 | 25,820 | 13,164 |
Total Current Liabilities | 18,745 | 15,979 | 23,801 | 30,639 | 44,154 | 33,417 |
Long-Term Leases | 853.02 | 1,112 | 481.21 | 428.68 | 612.97 | 325.47 |
Long-Term Unearned Revenue | - | - | - | 14.08 | 21.76 | - |
Pension & Post-Retirement Benefits | 475.74 | 509.22 | 595.61 | - | 39.38 | 141.72 |
Long-Term Deferred Tax Liabilities | 3,473 | 3,473 | 4,095 | 3,309 | 2,264 | 2,372 |
Other Long-Term Liabilities | 73.51 | 72.75 | 0 | 64.39 | 102.44 | 22.38 |
Total Liabilities | 23,620 | 21,146 | 28,974 | 34,455 | 47,194 | 36,279 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 2,764 | 2,764 | 34,439 | 26,139 | 12,774 | 47,304 |
Additional Paid-In Capital | 103,195 | 103,195 | 103,235 | 100,586 | 125,443 | 50,358 |
Retained Earnings | -70,703 | -69,230 | -96,197 | -74,646 | -83,442 | -41,033 |
Treasury Stock | -57.9 | -57.9 | -51.77 | -51.77 | -51.77 | -12.93 |
Comprehensive Income & Other | 10,438 | 10,438 | 11,020 | 11,277 | 8,516 | 9,588 |
Total Common Equity | 45,636 | 47,109 | 52,445 | 63,304 | 63,240 | 66,204 |
Minority Interest | - | - | - | - | - | -3.15 |
Shareholders' Equity | 45,636 | 47,109 | 52,445 | 63,304 | 63,240 | 66,201 |
Total Liabilities & Equity | 69,256 | 68,255 | 81,419 | 97,760 | 110,434 | 102,479 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 10,582 | 10,811 | 18,716 | 16,519 | 18,145 | 19,624 |
Net Cash (Debt) | -7,430 | -7,318 | -12,688 | 1,170 | 6,624 | -881.79 |
Net Cash Growth | - | - | - | -82.34% | - | - |
Net Cash Per Share | -1154.12 | -1359.11 | -3307.13 | 605.84 | 4704.05 | -999.35 |
Filing Date Shares Outstanding | 5.52 | 5.52 | 4.59 | 3.48 | 1.7 | 1.26 |
Total Common Shares Outstanding | 5.52 | 5.52 | 4.59 | 3.48 | 1.7 | 1.26 |
Working Capital | -9,866 | -8,485 | -10,546 | -602.11 | -2,265 | -7,145 |
Book Value Per Share | 8269.99 | 8536.89 | 11422.49 | 18166.44 | 37141.20 | 52484.85 |
Tangible Book Value | 45,630 | 47,101 | 52,429 | 63,280 | 61,111 | 66,196 |
Tangible Book Value Per Share | 8268.90 | 8535.45 | 11418.95 | 18159.49 | 35890.75 | 52478.35 |
Land | 34,379 | 34,379 | 42,519 | 42,211 | 37,158 | 37,158 |
Buildings | 6,388 | 6,833 | 8,531 | 8,353 | 8,337 | 8,329 |
Machinery | 350.11 | 6,835 | 6,634 | 7,886 | 9,144 | 7,828 |
Construction In Progress | 55 | - | 14.08 | - | - | - |